Poll: What does the future look like for single cell genomics?

With Fluidigm stepping aside and a slew of competitors looking to stake their claim, the world of single cell genomics…

Tempus generates chatter at #ASCO2017

Chicago, IL – Many exciting announcements have been made at ASCO this year, with our favorite picks highlighted here. One…

ASCO Musings: Diagnostics and Research Tools Takeaways from ASCO17

Chicago, IL June 6, 2017 – My colleague and I spent a few days wandering around the exhibit hall at…

Competitors Jostle for Share as Fluidigm Signals Deprioritization of Single-Cell Genomics

Los Angeles, CA May 31, 2017 – In Fluidigm’s Q1 2017 earnings call, Chris Linthwaite signaled the company’s deprioritization of single…

Competitors Jostle for Share as Fluidigm Signals Deprioritization of Single-Cell Genomics

Los Angeles, CA May 31, 2017 – In Fluidigm’s Q1 2017 earnings call, Chris Linthwaite signaled the company’s deprioritization of…

Talking Healthcare Analytics with Wout Brusselaers, CEO of Deep 6 AI

I recently had the pleasure to sit down with Wout Brusselaers, founder and CEO of South by Southwest Accelerator Pitch…

AGBT 2017: DeciBio Highlights

Hollywood, FL February 17, 2017 – We attended AGBT 2017, and had a chance to talk with multiple vendors and…

NanoString poised to make a play in clinical sequencing with Hyb & Seq

Hollywood, FL – Exciting times are upon us again at AGBT with multiple announcements from life science research tools players.…

Illumina, Bio-Rad, and 10X Genomics look to take advantage of the market that Fluidigm built

Santa Monica, CA – A year after announcing their partnership, Bio-Rad and Illumina launched their Single-Cell Sequencing Solution at the…

Diagnostic Biomarkers for Cancer Immunotherapy – Updated Jan. 2017

We continue to track the immuno-oncology (I/O) space closely and have recently made some updates to our prior analysis (here:…

How can we help?

Avoid blind spots in your market. Get the insights you need to accelerate innovation.

Contact Us